• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤来源的外泌体在小鼠迟发型超敏反应模型中赋予抗原特异性免疫抑制作用。

Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model.

机构信息

Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.

出版信息

PLoS One. 2011;6(8):e22517. doi: 10.1371/journal.pone.0022517. Epub 2011 Aug 2.

DOI:10.1371/journal.pone.0022517
PMID:21829629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3149056/
Abstract

Exosomes are endosome-derived small membrane vesicles that are secreted by most cell types including tumor cells. Tumor-derived exosomes usually contain tumor antigens and have been used as a source of tumor antigens to stimulate anti-tumor immune responses. However, many reports also suggest that tumor-derived exosomes can facilitate tumor immune evasion through different mechanisms, most of which are antigen-independent. In the present study we used a mouse model of delayed-type hypersensitivity (DTH) and demonstrated that local administration of tumor-derived exosomes carrying the model antigen chicken ovalbumin (OVA) resulted in the suppression of DTH response in an antigen-specific manner. Analysis of exosome trafficking demonstrated that following local injection, tumor-derived exosomes were internalized by CD11c+ cells and transported to the draining LN. Exosome-mediated DTH suppression is associated with increased mRNA levels of TGF-β1 and IL-4 in the draining LN. The tumor-derived exosomes examined were also found to inhibit DC maturation. Taken together, our results suggest a role for tumor-derived exosomes in inducing tumor antigen-specific immunosuppression, possibly by modulating the function of APCs.

摘要

外泌体是由大多数细胞类型(包括肿瘤细胞)分泌的起源于内体的小膜囊泡。肿瘤来源的外泌体通常包含肿瘤抗原,并已被用作肿瘤抗原的来源,以刺激抗肿瘤免疫反应。然而,许多报道还表明,肿瘤来源的外泌体可以通过不同的机制促进肿瘤免疫逃逸,其中大多数机制与抗原无关。在本研究中,我们使用迟发型超敏反应(DTH)的小鼠模型,证明了局部给予携带模型抗原鸡卵清蛋白(OVA)的肿瘤来源的外泌体可特异性抑制 DTH 反应。对外泌体运输的分析表明,局部注射后,肿瘤来源的外泌体被 CD11c+细胞内化,并运送到引流淋巴结。外泌体介导的 DTH 抑制与引流淋巴结中 TGF-β1 和 IL-4 的 mRNA 水平升高有关。检查的肿瘤来源的外泌体也被发现抑制 DC 成熟。总之,我们的研究结果表明,肿瘤来源的外泌体可能通过调节 APC 的功能,在诱导肿瘤抗原特异性免疫抑制中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/af17fab88870/pone.0022517.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/a701d9d4c520/pone.0022517.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/479ddf51468d/pone.0022517.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/db3bd2a6cdef/pone.0022517.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/d141dd2a63ef/pone.0022517.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/8ca1f76f5274/pone.0022517.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/4809a74e6c5a/pone.0022517.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/af17fab88870/pone.0022517.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/a701d9d4c520/pone.0022517.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/479ddf51468d/pone.0022517.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/db3bd2a6cdef/pone.0022517.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/d141dd2a63ef/pone.0022517.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/8ca1f76f5274/pone.0022517.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/4809a74e6c5a/pone.0022517.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94ab/3149056/af17fab88870/pone.0022517.g007.jpg

相似文献

1
Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model.肿瘤来源的外泌体在小鼠迟发型超敏反应模型中赋予抗原特异性免疫抑制作用。
PLoS One. 2011;6(8):e22517. doi: 10.1371/journal.pone.0022517. Epub 2011 Aug 2.
2
Orally Administered Exosomes Suppress Mouse Delayed-Type Hypersensitivity by Delivering miRNA-150 to Antigen-Primed Macrophage APC Targeted by Exosome-Surface Anti-Peptide Antibody Light Chains.口服给予外泌体通过将 miRNA-150 递送至外泌体表面抗肽抗体轻链靶向的抗原致敏巨噬细胞 APC 来抑制小鼠迟发型超敏反应。
Int J Mol Sci. 2020 Aug 2;21(15):5540. doi: 10.3390/ijms21155540.
3
Plasma-derived MHC class II+ exosomes from tumor-bearing mice suppress tumor antigen-specific immune responses.荷瘤小鼠血浆来源的 MHC Ⅱ类+外泌体抑制肿瘤抗原特异性免疫应答。
Eur J Immunol. 2012 Jul;42(7):1778-84. doi: 10.1002/eji.201141978.
4
Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive.源自表达FasL的基因改造树突状细胞的外泌体具有抗炎和免疫抑制作用。
Mol Ther. 2006 Feb;13(2):289-300. doi: 10.1016/j.ymthe.2005.09.015. Epub 2005 Nov 7.
5
Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4.用经基因改造以表达IL-4的树突状细胞衍生的外泌体有效治疗炎症性疾病模型。
J Immunol. 2007 Aug 15;179(4):2242-9. doi: 10.4049/jimmunol.179.4.2242.
6
MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner.血浆中的MHC II类外泌体以抗原特异性和Fas配体/Fas依赖的方式抑制炎症。
J Immunol. 2007 Aug 15;179(4):2235-41. doi: 10.4049/jimmunol.179.4.2235.
7
Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.对经转化生长因子β2处理的抗原呈递细胞体外激活的T细胞的体内调节特性分析。
Invest Ophthalmol Vis Sci. 2000 May;41(6):1410-21.
8
B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function.B7-1/2,但不是 PD-L1/2 分子,在 IL-10 处理的耐受性 DC 和 DC 衍生的外泌体中对于体内功能是必需的。
Eur J Immunol. 2009 Nov;39(11):3084-90. doi: 10.1002/eji.200939407.
9
Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.白血病衍生的外泌体通过下调TGF-β1表达增强抗白血病免疫
Cell Physiol Biochem. 2017;44(1):240-254. doi: 10.1159/000484677. Epub 2017 Nov 9.
10
Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.通过口服分泌卵清蛋白的乳酸乳球菌诱导卵清蛋白特异性耐受。
Gastroenterology. 2007 Aug;133(2):517-28. doi: 10.1053/j.gastro.2007.04.073. Epub 2007 May 3.

引用本文的文献

1
The role of exosomes in immunopathology and potential therapeutic implications.外泌体在免疫病理学中的作用及潜在治疗意义。
Cell Mol Immunol. 2025 Jul 14. doi: 10.1038/s41423-025-01323-5.
2
Potential Effect of Extracellular Vesicles in Clinical Settings of Lymphoma.细胞外囊泡在淋巴瘤临床环境中的潜在作用。
Indian J Clin Biochem. 2025 Jan;40(1):12-24. doi: 10.1007/s12291-023-01156-x. Epub 2023 Oct 14.
3
Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies.利用外泌体的力量用于血液系统恶性肿瘤的诊断、预后评估和治疗。

本文引用的文献

1
Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis.黑色素瘤细胞释放的外泌体使前哨淋巴结为肿瘤转移做好准备。
Cancer Res. 2011 Jun 1;71(11):3792-801. doi: 10.1158/0008-5472.CAN-10-4455. Epub 2011 Apr 8.
2
Tumor-derived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg).肿瘤来源的微囊泡诱导、扩增和上调人调节性 T 细胞(Treg)的生物学活性。
PLoS One. 2010 Jul 22;5(7):e11469. doi: 10.1371/journal.pone.0011469.
3
Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells.
Stem Cell Res Ther. 2025 Jan 7;16(1):6. doi: 10.1186/s13287-024-04125-0.
4
The theragnostic advances of exosomes in managing leukaemia.外泌体在白血病治疗诊断方面的进展
J Cell Mol Med. 2024 Dec;28(23):e70052. doi: 10.1111/jcmm.70052.
5
Tumor immune escape: extracellular vesicles roles and therapeutics application.肿瘤免疫逃逸:细胞外囊泡的作用和治疗应用。
Cell Commun Signal. 2024 Jan 2;22(1):9. doi: 10.1186/s12964-023-01370-3.
6
Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling.肿瘤来源的外泌体通过外泌体CD19抗原诱导初始激活,但通过转化生长因子-β信号传导损害CD19特异性嵌合抗原受体T细胞的功能。
Front Med. 2024 Feb;18(1):128-146. doi: 10.1007/s11684-023-1010-1. Epub 2023 Oct 23.
7
The clinical importance of the host anti-tumour reaction patterns in regional tumour draining lymph nodes in patients with locally advanced resectable gastric cancer: a systematic review and meta-analysis.局部进展期可切除胃癌患者区域肿瘤引流淋巴结中宿主抗肿瘤反应模式的临床重要性:系统评价和荟萃分析。
Gastric Cancer. 2023 Nov;26(6):847-862. doi: 10.1007/s10120-023-01426-w. Epub 2023 Sep 30.
8
Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations.树突状细胞疫苗:从传统方法到新一代的转变。
Cells. 2023 Aug 25;12(17):2147. doi: 10.3390/cells12172147.
9
Small extracellular vesicle TGF-β in cancer progression and immune evasion.小细胞外囊泡 TGF-β 在癌症进展和免疫逃逸中的作用。
Cancer Gene Ther. 2023 Oct;30(10):1309-1322. doi: 10.1038/s41417-023-00638-7. Epub 2023 Jun 21.
10
Extracellular Vesicles: New Classification and Tumor Immunosuppression.细胞外囊泡:新分类与肿瘤免疫抑制
Biology (Basel). 2023 Jan 10;12(1):110. doi: 10.3390/biology12010110.
肿瘤来源的外泌体中膜相关的 HSP72 通过 STAT3 介导小鼠和人源髓系来源抑制细胞的免疫抑制功能。
J Clin Invest. 2010 Feb;120(2):457-71. doi: 10.1172/JCI40483. Epub 2010 Jan 19.
4
Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma.IL-12 锚定的肾癌细胞衍生的外泌体增加体外特异性抗肿瘤反应的诱导:一种新的肾细胞癌疫苗。
Int J Oncol. 2010 Jan;36(1):133-40.
5
Exosomes in tumour immunity.肿瘤免疫中的外泌体
Curr Oncol. 2009 May;16(3):46-9. doi: 10.3747/co.v16i3.367.
6
Membrane vesicles as conveyors of immune responses.膜囊泡作为免疫反应的传递者。
Nat Rev Immunol. 2009 Aug;9(8):581-93. doi: 10.1038/nri2567. Epub 2009 Jun 5.
7
Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.卵巢癌释放的外泌体的全身存在及促肿瘤生长作用
Cancer Lett. 2009 Jun 8;278(1):73-81. doi: 10.1016/j.canlet.2008.12.028. Epub 2009 Feb 1.
8
Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction.来自耐受小鼠支气管肺泡灌洗液的外泌体可预防过敏反应。
J Immunol. 2008 Jul 15;181(2):1519-25. doi: 10.4049/jimmunol.181.2.1519.
9
Human tumor-derived exosomes down-modulate NKG2D expression.人肿瘤来源的外泌体下调NKG2D表达。
J Immunol. 2008 Jun 1;180(11):7249-58. doi: 10.4049/jimmunol.180.11.7249.
10
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.肿瘤诱导的髓源性抑制细胞介导的免疫耐受和免疫抑制
Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x.